Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | ANPEP | P15144 | 3/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 5/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3585497 | 0.91 | HTR2A (0.56) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL19143919 | 0.89 | TDP1 (0.54) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL18531940 | 0.89 | EPHX1 (0.64) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL172466 | 0.89 | S1PR1 (0.49) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL8599042 | 0.89 | ANPEP (0.50) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL5323248 | 0.89 | S1PR1 (0.49) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL3442080 | 0.88 | HTR2A (0.52) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL11769571 | 0.88 | EPHX1 (0.70) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL13452965 | 0.86 | ANPEP (0.48) | EPHX1ANPEPERAP1ERAP2TAAR1 | |
| SCHEMBL1148969 | 0.86 | ANPEP (0.48) | EPHX1ANPEPERAP1ERAP2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729588-A1 | CATIONIC ELECTRODEPOSITED PAINT COMPOSITION AND METHOD FOR FORMING CURED ELECTRODEPOSITED COATING | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-12480005-B2 | Method for preparing cationic electrodeposition coating composition | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20220332960-A1 | CATIONIC ELECTRODEPOSITION COATING COMPOSITION | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2022-10-20 | — | — | US | disclosed |
| US-20220282098-A1 | METHOD FOR PREPARING CATIONIC ELECTRODEPOSITION COATING COMPOSITION | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2022-09-08 | — | — | US | disclosed |
| EP-3354700-B1 | METHOD FOR PREPARING CATIONIC ELECTRODEPOSITION COATING MATERIAL COMPOSITION | NIPPON PAINT AUTOMOTIVE COATINGS CO LTD (JP) | 2022-07-20 | — | — | EP | disclosed |
| EP-3998316-A1 | CATIONIC ELECTRODEPOSITION COATING COMPOSITION | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2022-05-18 | — | — | EP | disclosed |
| EP-3978576-A1 | METHOD FOR PREPARING CATIONIC ELECTRODEPOSITION COATING COMPOSITION | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2022-04-06 | — | — | EP | disclosed |
| WO-2021006220-A1 | CATIONIC ELECTRODEPOSITION COATING COMPOSITION | 日本ペイント・オートモーティブコーティングス株式会社 | 2021-01-14 | — | — | WO | disclosed |
| WO-2020241590-A1 | METHOD FOR PREPARING CATIONIC ELECTRODEPOSITION COATING COMPOSITION | 日本ペイント・オートモーティブコーティングス株式会社 | 2020-12-03 | — | — | WO | disclosed |
| EP-3354701-B1 | METHOD FOR PREPARING CATIONIC ELECTRODEPOSITION COATING COMPOSITION | NIPPON PAINT AUTOMOTIVE COATINGS CO LTD (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-5840736-A | PEPTIDES FOR NERVE GROWTH | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-11-24 | — | — | US | disclosed |
| WO-1998020891-A1 | METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-05-22 | — | — | WO | disclosed |
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| EP-0797567-A1 | NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | Vertex Pharmaceuticals Incorporated (US) | 1997-10-01 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5543423-A | USED IN MULTI-DRUG RESISTANCE CANCER THERAPY | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 1996-08-06 | — | — | US | disclosed |
| WO-1996015101-A1 | NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1996-05-23 | — | — | WO | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |